Alnylam Pharmaceuticals (ALNY) Selling, General & Administrative (2009 - 2026)
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | 351.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 347.92 Mn |
| Mar 31, 2026 | 322.55 Mn |
| Dec 31, 2025 | 325.37 Mn |
| Sep 30, 2025 | 322.08 Mn |
| Jun 30, 2025 | 323.31 Mn |
| Mar 31, 2025 | 239.95 Mn |
| Dec 31, 2024 | 295.34 Mn |
| Sep 30, 2024 | 220.99 Mn |
| Jun 30, 2024 | 248.40 Mn |
| Mar 31, 2024 | 210.80 Mn |
| Dec 31, 2023 | 198.12 Mn |
| Sep 30, 2023 | 199.18 Mn |
| Jun 30, 2023 | 214.69 Mn |
| Mar 31, 2023 | 183.66 Mn |
| Dec 31, 2022 | 210.34 Mn |
| Sep 30, 2022 | 235.86 Mn |
| Jun 30, 2022 | 169.98 Mn |
| Mar 31, 2022 | 154.47 Mn |
| Dec 31, 2021 | 186.38 Mn |
| Sep 30, 2021 | 142.08 Mn |